Cite
HARVARD Citation
Reddy, M. et al. (2020). Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission. Transfusion and apheresis science. p. . [Online].